77 results
Page 3 of 4
424B5
0relt8b kkoe
3 Jun 19
Prospectus supplement for primary offering
4:01pm
8-K
1s2bl5oa 0ix
21 Mar 19
Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter
4:40pm
8-K
EX-99.1
nkxetp8
21 Mar 19
Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter
4:40pm
424B5
jfhwet8d
4 May 18
Prospectus supplement for primary offering
6:13am
8-K
EX-1.1
qp3vt
4 May 18
Sientra Commences Public Offering of Common Stock
6:07am
424B5
g62lqz5n
30 Apr 18
Prospectus supplement for primary offering
7:05am